D-Index & Metrics Best Publications
Neville F. Hacker

Neville F. Hacker

University of New South Wales
Australia

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

His primary scientific interests are in Surgery, Carcinoma, Ovarian cancer, Internal medicine and Cancer. His Carcinoma research incorporates themes from Survival rate, Retrospective cohort study, Stage, Radical Vulvectomy and Survival analysis. His studies in Ovarian cancer integrate themes in fields like Endometriosis, Gynecology, Pathology, Cell adhesion molecule and General surgery.

As part of the same scientific family, Neville F. Hacker usually focuses on Gynecology, concentrating on Obstetrics and intersecting with Cervix and Ectopic pregnancy. While the research belongs to areas of Internal medicine, Neville F. Hacker spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Combination chemotherapy. His Cancer research includes themes of Cancer research, Methylation and DNA methylation.

His most cited work include:

  • Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer (879 citations)
  • PRIMARY CYTOREDUCTIVE SURGERY FOR EPITHELIAL OVARIAN CANCER (384 citations)
  • Practical gynecologic oncology (368 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Ovarian cancer, Internal medicine, Surgery, Oncology and Cancer. His work carried out in the field of Ovarian cancer brings together such families of science as Cancer research, Metastasis, Immunology and Pathology. The concepts of his Pathology study are interwoven with issues in Ovary and Adenocarcinoma.

In his research on the topic of Internal medicine, Immunotherapy is strongly related with Gastroenterology. His work on Disease expands to the thematically related Surgery. His research investigates the connection between Cancer and topics such as Gynecology that intersect with problems in Obstetrics, Hysterectomy, Endometrial cancer, Referral and Incidence.

He most often published in these fields:

  • Ovarian cancer (36.86%)
  • Internal medicine (31.73%)
  • Surgery (26.28%)

What were the highlights of his more recent work (between 2011-2021)?

  • Ovarian cancer (36.86%)
  • Cancer (22.12%)
  • Internal medicine (31.73%)

In recent papers he was focusing on the following fields of study:

Neville F. Hacker mostly deals with Ovarian cancer, Cancer, Internal medicine, Cancer research and Oncology. Neville F. Hacker has researched Ovarian cancer in several fields, including Cancer cell, Serous fluid, Antibody and Metastasis. The Cancer study combines topics in areas such as Gynecology, Disease, MEDLINE and Ascites.

His Internal medicine research is multidisciplinary, incorporating perspectives in Wnt signaling pathway and Drug resistance. The study incorporates disciplines such as Cell migration, DNA methylation, Ovarian carcinoma, Ovarian cancer cells and DNA repair in addition to Cancer research. His Oncology research incorporates elements of Chemotherapy, Regimen, Epithelial ovarian cancer, Stage and Survival analysis.

Between 2011 and 2021, his most popular works were:

  • Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines (139 citations)
  • Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. (127 citations)
  • Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer (75 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Neville F. Hacker spends much of his time researching Ovarian cancer, Cancer, Cancer research, Internal medicine and Gynecology. Neville F. Hacker has included themes like Wnt signaling pathway, Cancer cell, Serous fluid, Metastasis and Survival analysis in his Ovarian cancer study. His Cancer study also includes

  • Disease which is related to area like Ascites, Diaphragmatic Stripping, Thoracoscopy, Chemotherapy and Surgery,
  • Mass screening and related Vagina, Vaginal neoplasm, Dermatology and Vulvar neoplasm.

His study in Cancer research is interdisciplinary in nature, drawing from both Ovarian carcinoma, SFRP4, DNA methylation and Prostate cancer. Neville F. Hacker usually deals with Internal medicine and limits it to topics linked to Oncology and Stage and Cell. His study looks at the relationship between Gynecology and topics such as Standardized rate, which overlap with Vulvar cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer

Zhen Zhang;Robert C. Bast;Yinhua Yu;Jinong Li.
Cancer Research (2004)

1257 Citations

PRIMARY CYTOREDUCTIVE SURGERY FOR EPITHELIAL OVARIAN CANCER

N F Hacker;J S Berek;L D Lagasse;R K Nieberg.
Obstetrics & Gynecology (1983)

616 Citations

Practical gynecologic oncology

Jonathan S. Berek;Neville F. Hacker.
(1989)

571 Citations

Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial

Pierluigi Benedetti Panici;Angelo Maggioni;Neville Hacker;Fabio Landoni.
Journal of the National Cancer Institute (2005)

560 Citations

Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva.

James M. Heaps;Yao S. Fu;Fredrick J. Montz;Neville F. Hacker.
Gynecologic Oncology (1990)

442 Citations

Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight.

I. Juraskova;P. Butow;R. Robertson;L. Sharpe.
Psycho-oncology (2003)

382 Citations

Survival of patients following secondary cytoreductive surgery in ovarian cancer.

Berek Js;Hacker Nf;Lagasse Ld;Nieberg Rk.
Obstetrics & Gynecology (1983)

380 Citations

Reproductive and other factors and risk of epithelial ovarian cancer: An australian case-control study

David Purdie;Adèle Green;Christopher Bain;Victor Siskind.
International Journal of Cancer (1995)

330 Citations

Distant metastases in epithelial ovarian carcinoma

Jacques Dauplat;Neville F. Hacker;Roberta K. Nieberg;Jonathan S. Berek.
Cancer (1987)

305 Citations

Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA

Jonathan S. Berek;Candace Howe;Leo D. Lagasse;Neville F. Hacker.
Gynecologic Oncology (2005)

266 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Neville F. Hacker

Dennis S. Chi

Dennis S. Chi

Memorial Sloan Kettering Cancer Center

Publications: 51

Robert E. Bristow

Robert E. Bristow

University of California, Irvine

Publications: 51

Jonathan S. Berek

Jonathan S. Berek

Stanford University

Publications: 51

Giovanni Scambia

Giovanni Scambia

Catholic University of the Sacred Heart

Publications: 48

Jalid Sehouli

Jalid Sehouli

Charité - University Medicine Berlin

Publications: 47

David M. Gershenson

David M. Gershenson

The University of Texas MD Anderson Cancer Center

Publications: 43

Penelope M. Webb

Penelope M. Webb

QIMR Berghofer Medical Research Institute

Publications: 43

Ignace Vergote

Ignace Vergote

KU Leuven

Publications: 41

Claes G. Tropé

Claes G. Tropé

University of Oslo

Publications: 40

Robert C. Bast

Robert C. Bast

The University of Texas MD Anderson Cancer Center

Publications: 36

David M. Purdie

David M. Purdie

Global Blood Therapeutics (United States)

Publications: 35

Yong Sang Song

Yong Sang Song

Seoul National University

Publications: 34

Adèle C. Green

Adèle C. Green

QIMR Berghofer Medical Research Institute

Publications: 32

Beth Y. Karlan

Beth Y. Karlan

University of California, Los Angeles

Publications: 32

Eleftherios P. Diamandis

Eleftherios P. Diamandis

Mount Sinai Hospital

Publications: 30

Maurie Markman

Maurie Markman

The University of Texas MD Anderson Cancer Center

Publications: 30

Trending Scientists

Murray Z. Frank

Murray Z. Frank

Shanghai Jiao Tong University

Yan Yan

Yan Yan

University of Southern California

Moo Been Chang

Moo Been Chang

National Central University

Jianmin Ma

Jianmin Ma

Hunan University

Gustav Vaaje-Kolstad

Gustav Vaaje-Kolstad

Norwegian University of Life Sciences

Michael Fromm

Michael Fromm

Charité - University Medicine Berlin

Chin Ha Chung

Chin Ha Chung

Seoul National University

Robert H. Vonderheide

Robert H. Vonderheide

University of Pennsylvania

Jane M Ussher

Jane M Ussher

Western Sydney University

Alan G. Kamhi

Alan G. Kamhi

University of North Carolina at Greensboro

Sally J Ozonoff

Sally J Ozonoff

University of California, Davis

Markolf Hanefeld

Markolf Hanefeld

TU Dresden

Ryan J. Uitti

Ryan J. Uitti

Mayo Clinic

Yoshio Yamaoka

Yoshio Yamaoka

Kyoto University

Michael S. Niederman

Michael S. Niederman

Cornell University

Clement J. McDonald

Clement J. McDonald

National Institutes of Health

Something went wrong. Please try again later.